Atlanta—Despite progress in recent years in the diagnosis and treatment of sickle cell disease and thalassemia,
significant improvements are still needed in providing adequate care.
That was the consensus of various researchers who presented new study data pertaining to these blood disorders at the 49th Annual Meeting of the American Society of Hematology held here in December.
“As physicians, we need to better understand how to treat . . . patients from childhood through their adult life,” said Marilyn Telen,
MD, the Division Chief of Hematology at Duke University in Durham,
NC. “Further, by understanding how to effectively mitigate the [adverse] consequences of [treatment], we can better serve a broad range of patients who suffer from red blood cell disorders,”
Hampton T. Strides Made in Red Blood Cell Disorders, but Substantial Barriers to Care Remain. JAMA. 2008;299(4):395–396. doi:10.1001/jama.2008.3
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: